Arch Therapeutics Stock Price, News & Analysis
Company Description
Arch Therapeutics (OTC: ARTH) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector.
ARTH stock has declined 86.4% over the past year. Shares last traded at $0.1608.
This page provides a comprehensive overview of ARTH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Arch Therapeutics (ARTH) stock last traded at $0.1608. Over the past 12 months, the stock has lost 86.4%.
Latest News
Arch Therapeutics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all ARTH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ARTH Company Profile & Sector Positioning
Arch Therapeutics (ARTH) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.